Navigation Links
Synovics Pharmaceuticals Announces the Appointment of Jyotindra Gange as Principal Executive Officer
Date:7/10/2008

s; market and customer acceptance and demand for its products; the Company's possible dependence on continued or future revenues from significant customers; the use of estimates in the preparation of the Company's financial statements; the potential for competitors to file ANDAs prior to any filing by the Company pertaining to the same target brand; the impact of competitive products and pricing on products, including the launch of authorized generics; the ability to launch new products in the timeframes it expects; the availability of raw materials or "APIs"; the availability of any product it may purchase; the regulatory environment; the Company's exposure to product liability and other lawsuits and contingencies; the increasing cost of insurance and the availability of product liability insurance coverage; the Company's timely and successful completion of strategic initiatives, including integrating companies and products it may acquire and implementing its Front-End India strategy; fluctuations in operating results, including the effects on such results from spending for research and development, sales and marketing activities and patent challenge activities; the inherent uncertainty associated with financial projections; the outcome of ongoing efforts to improve Kirks operational efficiency and customer performance; changes in generally accepted accounting principles, fluctuations in operating results; capital adequacy; statements of future plans relating to the Company's capital needs, product development and filings with the FDA, viability, application or continuation of the Company's business licenses including Drug, Enforcement and Administrations licenses for scheduled drugs; business and growth strategies; statements specifically concerning the successful closing of acquisitions, and satisfying closing conditions of any current or future financial transactions including debt or equity requirements, regulatory requirements; and meeting conditions set by po
'/>"/>
SOURCE Synovics Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Synovics Pharmaceuticals forms a Strategic Joint Venture with Maneesh Pharmaceuticals
2. Synovics Pharmaceuticals Files Its Second Quarter, 2008 Form 10Q with the SEC
3. Synovics Pharmaceuticals Announces Execution of Hormonal Manufacture and Supply Contract
4. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
5. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
6. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
7. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
8. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
9. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
10. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
11. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... (PRWEB) July 31, 2014 The ... the hiring of new dentist Dr. Jonathan Oudin, DDS, ... had previously practiced in Barrow, Alaska, for three years. ... for Dentistry hired Dr. Oudin to help take on ... for Dentistry to continue growing and serving the greater ...
(Date:7/31/2014)... reporting cognitive difficulties after a head injury are usually ... really a concussion? A new study published by University ... same symptoms are common to concussions and to injuries ... cervical/vestibular injuries. , The research was based on responses ... were professional athletes who were being treated at ...
(Date:7/31/2014)... Millions of people avoid going to ... experiences as a child and some simply fear the ... a highly experienced NJ cosmetic dentist, Dr. Richard Champagne ... dental procedure. To help these patients receive the ... Smiles offer several sedation dentistry techniques. , Sedation dentistry ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Transvaginal mesh ... continue to move forward in the federal multidistrict litigation ... Virginia, Bernstein Liebhard LLP reports. According to an Order ... consider certain defense motions now pending before the Court. ... Magistrate Judge on Tuesday, August 5th at 2:30 p.m. ...
(Date:7/31/2014)... 2014 Model moms are believers. PBS has ... positions in the field have grown exponentially in the last ... thriving industry, there are associated myths that need to be ... Frontier Nursing University . Celebrating 75 years in 2014, ... in the nation. “Frontier is changing the face of ...
Breaking Medicine News(10 mins):Health News:Dr. Jonathan Oudin to Join Alaska Center for Dentistry at Wasilla Location 2Health News:Is it really a concussion? Symptoms overlap with neck injuries so diagnosis is tough call 2Health News:Is it really a concussion? Symptoms overlap with neck injuries so diagnosis is tough call 3Health News:Champagne Smiles is Thrilled to Now Offer Sedation Dentistry to their Patients 2Health News:Ethicon Transvaginal Mesh Lawsuits Move Forward, With Scheduling of Hearing in Federal Litigation, Bernstein Liebhard LLP Reports 2Health News:Ethicon Transvaginal Mesh Lawsuits Move Forward, With Scheduling of Hearing in Federal Litigation, Bernstein Liebhard LLP Reports 3Health News:Frontier Nursing University Busts Midwifery Myths In Celebration of 75th Anniversary 2Health News:Frontier Nursing University Busts Midwifery Myths In Celebration of 75th Anniversary 3Health News:Frontier Nursing University Busts Midwifery Myths In Celebration of 75th Anniversary 4Health News:Frontier Nursing University Busts Midwifery Myths In Celebration of 75th Anniversary 5
... need for more talking therapies for people with depression//. ... two talking therapy pilot centers in Doncaster and Newham, aimed ... to work. If it succeeded other centers could also be ... says evidence from its helpline callers show 83% take medication ...
... by scientists at UCSF, Celera Genomics and The Cleveland Clinic ... heart attack, or myocardial infarction (MI). ,One of ... for early stages of clotting. When clotting occurs in a ... gene mutations that increase heart attack risk can help identify ...
... from cigarette smoke of parents can affect their infants. The ... are associated with tobacco smoke in the urine of nearly ... ,"The take home message is, 'Don't smoke around your kids,'" ... Cancer Prevention at The Cancer Center at the University of ...
... is time for the medical students in Scotland to voice ... held demonstrations //outside the Scottish Parliament to show their disapproval. ... were very much close to the top-up fees. But ministers ... fees. , But last year the Scottish ministers ...
... has cut down payments for health care providers. Angered ... //in to this matter. The insurers reduce payment to ... are forced out of practice and have to turn ... this MedChi said in a letter to Attorney General ...
... shrouded in ambiguity, though studies have hinted at the ... a novel report has suggested that growth hormone, as ... of calorie restriction and does contribute to extending life. ... University in Springfield and his team studied the effects ...
Cached Medicine News:Health News:Gene Variants Linked to Early Heart Attack Discovered 2Health News:Gene Variants Linked to Early Heart Attack Discovered 3Health News:Gene Variants Linked to Early Heart Attack Discovered 4Health News:Cancer Causing Chemicals Found In Urine Of Babies Whose Parents Smoke 2
(Date:7/31/2014)... LONDON , July 31, 2014 ... for the medical industries, announced today the incorporation of genae UK ... United Kingdom has one of the largest medical device ... in 2012 and it is projected to increase by a CAGR ... billion in 2012, equal to 9.5% of GDP. Despite recessionary pressures, ...
(Date:7/31/2014)... July 31, 2014 Astellas has appointed ... corporate and employee communications in the Americas region. ... , senior vice president, chief communications officer. In ... and leading corporate brand initiatives and reputation management ... and South America . She ...
(Date:7/31/2014)... 2014 The Galien Foundation today announced the ... USA Awards. The Prix Galien Award ... the technical, scientific and clinical research skills necessary to ... brings the highest number of nominees since the inception ... Nominees include biomedical products across three categories – biotechnology, ...
Breaking Medicine Technology:genae Opens Offices in London 2Astellas Hires Industry Veteran Moyra Knight as Head of Corporate and Employee Communications 2The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 2The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 3The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 4The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 5
... , DUBLIN, Ohio , July 15 Cardinal ... LLC, expanding the company,s presence in specialty pharmaceutical services. , ... Healthcare Solutions Holding ... Pathways and P4 Healthcare. These businesses serve key participants across the ...
... , SAN MATEO, Calif. , July 15 Merz ... to doctors, offices throughout the U.S.  Previously only available in Europe ... (FDA). , , , ... study published in the June issue of Phlebology , leading experts ...
Cached Medicine Technology:Cardinal Health Completes Acquisition of Healthcare Solutions Holding 2Cardinal Health Completes Acquisition of Healthcare Solutions Holding 3Merz Aesthetics™ Asclera™ (polidocanol) Injection Now Available in Doctors' Offices Nationwide 2Merz Aesthetics™ Asclera™ (polidocanol) Injection Now Available in Doctors' Offices Nationwide 3Merz Aesthetics™ Asclera™ (polidocanol) Injection Now Available in Doctors' Offices Nationwide 4
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
Inquire...
Medicine Products: